09 November 2019

Much of the news from the annual National Cancer Research Institute (NCRI) conference, held in Glasgow this week, was about being able to diagnose cancer through blood tests a liquid biopsy - and the role of AI in assisting with this. To get a full overview of what was new at conference have a lookherehowever the piece most relevant to our community is the development of anAI blood test that can spot signs of brain tumour to speed up diagnosis.

Scientific updates from Sweden and Germany below

Pharmaceutical updates from the US and Israel now;

Immunologically cold tumours, are cancers that contain few infiltrating T cells and do not provoke a strong response by the immune system. Immunologically hot tumours contain high levels of infiltrating T cells and more antigens, making them more recognizable by the immune system and more likely to trigger a strong immune response.Cancers that are classically immunologically cold include glioblastomas.

Related stories:

If you found this story interesting or helpful,sign up to our weekly e-newsand keep up to date with all the latest from Brain Tumour Research.

See the article here:

Weekly pick of Neuroscience news from around the world - Brain Tumour Research